Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Eero, Kaasinen"'
Autor:
Taina Isotalo, Kalmer Innos, Eero Kaasinen, Sirpa Aaltomaa, Erkki Rintala, Riikka Järvinen, Eija Kelloniemi, Pekka Hellström
Publikováno v:
In Vivo
Background/aim Non-muscle invasive bladder carcinoma (NMIBC) is highly recurrent. We studied if 5-aminolevulinic acid (5-ALA) instillations before transurethral resection of bladder tumours (TURBT) and cystoscopy extend the time to recurrence during
Autor:
Eero Kaasinen, Marjo Seppänen, Timo Marttila, Markku H. Vaarala, Ville Sell, Tarmo Pekkarinen, Ileana Montoya Perez, Riikka Järvinen, Peter J. Boström, Otto Ettala, Sirpa Aaltomaa, Tapani Liukkonen
Publikováno v:
World Journal of Urology
Purpose To investigate the symptoms and delays in the clinical pathway of bladder cancer (BC). Methods This is a substudy of a prospective, randomized, multicenter phase III study (FinnBladder 9, NCT01675219) where the efficacy of photodynamic diagno
Autor:
Andreas Böhle, Eero Kaasinen, Joan Palou, Maximilian Burger, Shahrokh F. Shariat, Richard Zigeuner, Richard Sylvester, Virginia Hernández, Otakar Čapoun, Bas W.G. van Rhijn, Viktor Soukup, Daniel Cohen, Morgan Rouprêt, Marko Babjuk, Eva Comperat
Publikováno v:
European Urology. 71:447-461
Context The European Association of Urology (EAU) panel on Non–muscle-invasive Bladder Cancer (NMIBC) released an updated version of the guidelines on Non–muscle-invasive Bladder Cancer. Objective To present the 2016 EAU guidelines on NMIBC. Evid
Autor:
Richard Sylvester, Bas W.G. van Rhijn, Marko Babjuk, Morgan Rouprêt, Cathy Yuhong Yuan, Joan Palou, Maximilian Burger, J. Domínguez-Escrig, Andreas Böhle, Richard Zigeuner, Eero Kaasinen, Benoit Peyronnet, Shahrokh F. Shariat, Thomas Seisen, Harman Maxim Bruins, Nigel C. Cowan, Eva Comperat
Publikováno v:
European Urology. 70:1052-1068
Context There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Objective To systematically review the current literature c
Autor:
Mika Raitanen, Tapani Liukkonen, Erkki Rintala, Timo Marttila, Teuvo L.J. Tammela, Riikka Järvinen, Marjo Seppänen, Peter J. Boström, Pekka Hellström, Sirpa Aaltomaa, Markku J Leskinen, Eero Kaasinen
Publikováno v:
European Urology. 70:341-347
Background Patients with non–muscle-invasive bladder cancer (NMIBC) belonging to the intermediate-risk group should be treated with intravesical instillations to prevent recurrence and progression. Objective We compared the outcome of a monthly mai
Autor:
Brant A. Inman, Sigurdur Gudjonsson, Alison Birtle, Can Ali Tatar, Richard Sylvester, Matthew R. Sydes, Eduardo Solsona, Jorg R. Oddens, Eero Kaasinen, Cosimo De Nunzio, Sten Holmäng, Marek Babjuk, Bedeir Ali-El-Dein, Kikuo Okamura, James N'Dow, Willem Oosterlinck
Publikováno v:
European urology, 69(2), 231-244. Elsevier
Context The European Association of Urology non-muscle-invasive bladder cancer (NMIBC) guidelines recommend that all low- and intermediate-risk patients receive a single immediate instillation of chemotherapy after transurethral resection of the blad
Autor:
Eero Kaasinen, Timo Marttila, Jukka Kallio, Jouko Viitanen, Markku H. Vaarala, Sirpa Aaltomaa, Kari Tuhkanen, Tapani Liukkonen, Veli-Matti Puolakka, Peter J. Boström, Riikka Järvinen, Erkki Rintala, Marjo Seppänen
Publikováno v:
European Urology. 68(4):611-617
Background Recurrent TaT1 non–muscle-invasive bladder cancer (NMIBC) patients should be treated with immediate instillation of chemotherapy after transurethral resection of bladder tumour followed by instillation therapy. Objective To present long-
Autor:
Shahrokh F. Shariat, Eva Comperat, Andreas Böhle, Morgan Rouprêt, Maximilian Burger, Marko Babjuk, Bas W.G. van Rhijn, Joan Palou Redorta, Richard Sylvester, Richard Zigeuner, Eero Kaasinen
Publikováno v:
European Urology. 64:639-653
Context The first European Association of Urology (EAU) guidelines on bladder cancer were published in 2002 [1]. Since then, the guidelines have been continuously updated. Objective To present the 2013 EAU guidelines on non–muscle-invasive bladder
Autor:
Hans Wijkström, Oddvar Mestad, Erkki Rintala, Staffan Jahnson, Per-Uno Malmström, Eero Kaasinen
Publikováno v:
Scandinavian journal of urology. 50(5)
The aim of this study was to compare the long-term efficacy of BCG monotherapy to alternating therapy of mitomycin C (MMC) and BCG in patients with carcinoma in situ (CIS).Between 1992 and 1997, 321 patients with CIS were randomized from Finland, Nor
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 46:411-417
Only a few studies with a long-term follow-up exist on patients with carcinoma in situ (CIS) treated with instillation therapy. The objective was to study the long-term outcome of patients with CIS after mitomycin C (MMC) monotherapy or alternating t